| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models
|
Pisano, C.
|
|
|
18 |
9 |
p. 1500-1505
|
artikel
|
| 2 |
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
|
Candelaria, M.
|
|
|
18 |
9 |
p. 1529-1538
|
artikel
|
| 3 |
Breast cancer follow-up: just a burden, or much more?
|
Tondini, C.
|
|
|
18 |
9 |
p. 1431-1432
|
artikel
|
| 4 |
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials
|
Conforti, R.
|
|
|
18 |
9 |
p. 1477-1483
|
artikel
|
| 5 |
Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial
|
Dedes, K.J.
|
|
|
18 |
9 |
p. 1493-1499
|
artikel
|
| 6 |
Epigenetic modulation of resistance to chemotherapy?
|
Brown, R.
|
|
|
18 |
9 |
p. 1429-1430
|
artikel
|
| 7 |
Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer
|
Coutant, C.
|
|
|
18 |
9 |
p. 1513-1517
|
artikel
|
| 8 |
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
|
Cornelio, D.B.
|
|
|
18 |
9 |
p. 1457-1466
|
artikel
|
| 9 |
Hematopoietic cell transplantation: progress and obstacles
|
Devetten, M.
|
|
|
18 |
9 |
p. 1450-1456
|
artikel
|
| 10 |
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes
|
Voso, M.T.
|
|
|
18 |
9 |
p. 1523-1528
|
artikel
|
| 11 |
In this issue
|
|
|
|
18 |
9 |
p. 1427
|
artikel
|
| 12 |
Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib
|
Boeck, S.
|
|
|
18 |
9 |
p. 1582-1583
|
artikel
|
| 13 |
Not credible: a subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Ann Oncol 2007; 18 Suppl 3: pp 1–75)
|
Coleman, M.P.
|
|
|
18 |
9 |
p. 1433-1435
|
artikel
|
| 14 |
Occasional FDG–PET recognition of in situ breast cancer
|
Vincenzi, B.
|
|
|
18 |
9 |
p. 1584-1585
|
artikel
|
| 15 |
Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer
|
Ruthotto, F.
|
|
|
18 |
9 |
p. 1518-1522
|
artikel
|
| 16 |
Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly schedule
|
Sessa, C.
|
|
|
18 |
9 |
p. 1548-1553
|
artikel
|
| 17 |
Preferences regarding end-of-life cancer care and associations with good-death concepts: a population-based survey in Japan
|
Sanjo, M.
|
|
|
18 |
9 |
p. 1539-1547
|
artikel
|
| 18 |
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
|
van den Beuken-van Everdingen, M.H.J.
|
|
|
18 |
9 |
p. 1437-1449
|
artikel
|
| 19 |
Questioning specialists’ attitudes to breast cancer follow-up in primary care
|
Donnelly, P.
|
|
|
18 |
9 |
p. 1467-1476
|
artikel
|
| 20 |
Reply to ‘Not credible: a subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Annals of Oncology 2007, vol 18, Suppl 3, pp1-75)’ by Michel P Coleman
|
Jönsson, B.
|
|
|
18 |
9 |
p. 1585-1587
|
artikel
|
| 21 |
Role of protease activated receptor-2 in tumor advancement of ovarian cancers
|
Jahan, I.
|
|
|
18 |
9 |
p. 1506-1512
|
artikel
|
| 22 |
Small tumor of the medial breast presenting with a contralateral lymph node involvement detected on positron emission tomography scan
|
Facchini, G.
|
|
|
18 |
9 |
p. 1579-1580
|
artikel
|
| 23 |
Table of Contents
|
|
|
|
18 |
9 |
p. i-ii
|
artikel
|
| 24 |
The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry
|
Wick, C.
|
|
|
18 |
9 |
p. 1580-1582
|
artikel
|
| 25 |
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer
|
Camara, O.
|
|
|
18 |
9 |
p. 1484-1492
|
artikel
|
| 26 |
Timely disclosure of progress in childhood cancer survival by ‘period’ analysis in the Automated Childhood Cancer Information System
|
Steliarova-Foucher, E.
|
|
|
18 |
9 |
p. 1554-1560
|
artikel
|
| 27 |
Up-to-date monitoring of childhood cancer long-term survival in Europe: leukaemias and lymphomas
|
Brenner, H.
|
|
|
18 |
9 |
p. 1569-1577
|
artikel
|
| 28 |
Up-to-date monitoring of childhood cancer long-term survival in Europe: methodology and application to all forms of cancer combined
|
Brenner, Hermann
|
|
|
18 |
9 |
p. 1561-1568
|
artikel
|
Tijdschrift beschrijving